One woman dies every nine days in Australia from domestic violence. In this “What Happens Next?” episode, leading experts examine the drivers behind this national emergency.
The issue of medicine-related harm is immense, and how to tackle it is an area of growing interest to governments and healthcare systems alike.
Nitazenes can be up to 50 times stronger than fentanyl. They’re not yet common in Australia, so now’s the time to implement policies to reduce their harm and limit their uptake.
Stigma within the healthcare system is being tackled head-on with the development of resources to help people with substance dependence access the care they need.
Researchers have completed Australia’s most detailed analysis of opioid tapering trajectories to date, with some findings that contradict current guidelines.
Government reforms are fighting the tactics that have fed a cultural acceptability of vaping, and a mistaken belief it has insignificant health risks.
Changes to the Pharmaceutical Benefits Scheme have influenced the way doctors prescribe opioids, but is it for the better?
Police drug-enforcement activities in Indonesia do more harm than good, and women bear the brunt of it. It’s time for Indonesia to decriminalise drug use, and expand health services.
The recent introduction of a private member’s bill to decriminalise drug use has started an important conversation about how our drug laws are harming people, and how we can improve them.
A new, long-acting formulation of the medication buprenorphine promises to improve the treatment of opioid dependence.
There's growing evidence that an escape from underlying physical or emotional pain is a common driver of many opioid overdoses.
Racism shapes the war on drugs, and we can't make black lives truly matter without major law reforms.
As we (hopefully) start to move out of the grip of the coronavirus pandemic, there's a variety of issues we need to retain in our conversations with, and about, men’s health.
Melbourne is set to get its second safe injecting facility, but objections to them continue to overshadow the enormous public health gains made.
New rules aim to curb opioid-related deaths in Australia. These changes are a step in the right direction, but we need to tread carefully to avoid unintended consequences.
The trumpeting of hydroxychloroquine's potential in treating COVID-19 raises ethical and safety concerns.
Maintaining or expanding addiction services is vital if we’re to avert a syndemic of opioid overdoses and COVID-19.
From dementia to depression to drug addiction, artificial brain stimulation has been hailed as a landmark medical technology for the future. But safeguards are needed if we want the benefits without the risks.
The recent controversy embroiling the Richmond injecting room is overshadowing its positive community impact.
Deliberately infecting people with a disease-causing agent as part of medical research can be ethically acceptable, and even necessary.
In the wake of the UN's groundbreaking drug policy commitment, the time is right for drug laws reform.
A new institute is leading the push to eliminate the 'faulty' justice of the death penalty.
The drug epidemic that's claimed thousands of lives in the US is swiftly becoming a threat to the health of many Australians.
A new study has looked at why some crystal meth users are more likely to experience mental health problems than others.
Dummy text
